Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michel Dahan currently holds 672,092 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michel Dahan has been a net seller of AKBA stock. They have purchased $0 and sold $662.4K worth of shares.
Michel Dahan's most recent insider trade was on May 13, 2024, when they sold 34,840 shares at $1.26 per share.
Michel Dahan serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 38 insider transactions totaling $662.4K over their tenure at the company.
Michel Dahan holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Michel Dahan has shown a selling trading pattern, with $0 in total purchases and $662.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michel Dahan was on Dec 12, 2018, when they sold $209.1K worth of AKBA shares. This transaction involved 23,385 shares at $8.94 per share.
Michel Dahan currently owns 672,092 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michel Dahan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michel Dahan has 38 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Michel Dahan and 40,000+ other insiders.